scorecardresearchFDC Share Price Live NSE, BSE, Today - FDC Stock Price

FDC

BSE: 531599 | NSE: FDC | ISIN: INE258B01022 | SECTOR: Biotechnology & Drugs

471.20 -4.05 (-0.85%)

24 May 2024, 09:59 (IST)
  • Open

    475.25
  • High

    482.75
  • Low

    466.10
  • Prev Close

    475.25
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    76.72B
  • Volume

    12.94K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    -
  • Ask

    -

Company Description

  • Biotechnology & Drugs
  • BSE

    531599
  • NSE

    FDC
  • ISIN

    INE258B01022

FDC Limited is an India-based company, which is principally engaged in the business of pharmaceuticals. The Company manufactures and distributes its range of generics, formulations, and active pharmaceuticals at its manufacturing plants. It also manufactures oral rehydration salts (ORS) and specialized formulations. It has a range of functional foods and beverages. Its active pharmaceutical ingredients (APIs) include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate, among others. It has its presence in various therapeutic segments, such as anti-infectives, gastrointestinal, ophthalmological, vitamins/ minerals/ dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.

Company Officers

  • Vijay Bhatt

    Chief Financial Officer
  • Ameya Chandavarkar

    Chief Executive Officer - International Business, Executive Director
  • Varsharani Katre

    Compliance Officer, Company Secretary
  • Mohan Chandavarkar

    Managing Director, Executive Director
  • Nandan Chandavarkar

    Joint Managing Director, Executive Director
  • Ashok Chandavarkar

    Executive Director